Relationship between Antibody 2F5 Neutralization of HIV-1 and Hydrophobicity of Its Heavy Chain Third Complementarity-Determining Region

被引:92
|
作者
Ofek, Gilad [1 ]
McKee, Krisha [1 ]
Yang, Yongping [1 ]
Yang, Zhi-Yong [1 ]
Skinner, Jeff [2 ]
Guenaga, F. Javier [1 ]
Wyatt, Richard [1 ]
Zwick, Michael B. [3 ]
Nabel, Gary J. [1 ]
Mascola, John R. [1 ]
Kwong, Peter D. [1 ]
机构
[1] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA
[2] NIAID, Bioinformat & Computat Biosci Branch, Off Cyber Infrastruct & Computat Biol, NIH, Bethesda, MD 20892 USA
[3] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; TRANSITION-STATE ANALOG; MONOCLONAL-ANTIBODIES; VENOM PHOSPHOLIPASE-A2; ENVELOPE GLYCOPROTEIN; ECTODOMAIN REGION; CRYSTAL-STRUCTURE; GP41; ECTODOMAIN; ANTI-GP41; 2F5; MEMBRANE;
D O I
10.1128/JVI.02257-09
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The membrane-proximal external region (MPER) of the HIV-1 gp41 transmembrane glycoprotein is the target of the broadly neutralizing antibody 2F5. Prior studies have suggested a two-component mechanism for 2F5-mediated neutralization involving both structure-specific recognition of a gp41 protein epitope and nonspecific interaction with the viral lipid membrane. Here, we mutationally alter a hydrophobic patch on the third complementarity-determining region of the heavy chain (CDR H3) of the 2F5 antibody and assess the abilities of altered 2F5 variants to bind gp41 and to neutralize diverse strains of HIV-1. CDR H3 alterations had little effect on the affinity of 2F5 variants for a peptide corresponding to its gp41 epitope. In contrast, strong effects and a high degree of correlation (P < 0.0001) were found between virus neutralization and CDR H3 hydrophobicity, as defined by predicted free energies of transfer from water to a lipid bilayer interface or to octanol. The effect of CDR H3 hydrophobicity on neutralization was independent of isolate sensitivity to 2F5, and CDR H3 variants with tryptophan substitutions were able to neutralize HIV-1 similar to 10-fold more potently than unmodified 2F5. A threshold was observed for increased hydrophobicity of the 2F5 CDR H3 loop beyond which effects on 2F5-mediated neutralization leveled off. Together, the results provide a more complete understanding of the 2F5 mechanism of HIV-1 neutralization and indicate ways to enhance the potency of MPER-directed antibodies.
引用
收藏
页码:2955 / 2962
页数:8
相关论文
共 50 条
  • [1] The Antibody 2F5 Third Complementarity-Determining Region of the Heavy Chain (CDRH3) Displays Length Plasticity for Binding and Neutralization
    Guenaga, F.
    Wyatt, R.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2011, 27 (10) : A45 - A45
  • [2] The long third complementarity-determining region of the heavy chain is important in the activity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5
    Zwick, MB
    Komori, HK
    Stanfield, RL
    Church, S
    Wang, M
    Parren, PWHI
    Kunert, R
    Katinger, H
    Wilson, IA
    Burton, DR
    JOURNAL OF VIROLOGY, 2004, 78 (06) : 3155 - 3161
  • [3] Improvement in affinity and HIV-1 neutralization by somatic mutation in the heavy chain first complementarity-determining region of antibodies triggered by HIV-1 infection
    Torán, JL
    Sánchez-Pulido, L
    Kremer, L
    del Real, G
    Valencia, A
    Martínez, C
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2001, 31 (01) : 128 - 137
  • [4] Characterization of a high-affinity human antibody with a disulfide bridge in the third complementarity-determining region of the heavy chain
    Almagro, Juan Carlos
    Raghunathan, Gopalan
    Beil, Eric
    Janecki, Dariusz J.
    Chen, Qiang
    Dinh, Thai
    LaCombe, Ann
    Connor, Judy
    Ware, Mark
    Kim, Paul H.
    Swanson, Ronald V.
    Fransson, Johan
    JOURNAL OF MOLECULAR RECOGNITION, 2012, 25 (03) : 125 - 135
  • [5] Ablation of the Complementarity-Determining Region H3 Apex of the Anti-HIV-1 Broadly Neutralizing Antibody 2F5 Abrogates Neutralizing Capacity without Affecting Core Epitope Binding
    Julien, Jean-Philippe
    Huarte, Nerea
    Maeso, Ruben
    Taneva, Stefka G.
    Cunningham, Annie
    Nieva, Jose L.
    Pai, Emil F.
    JOURNAL OF VIROLOGY, 2010, 84 (09) : 4136 - 4147
  • [6] How Tolerance Shapes the Development of the HIV-1 Broadly Neutralizing Antibody 2F5
    Finney, Joel T.
    Yang, Guang
    Kuraoka, Masayuki
    Nojima, Takuya
    Verkoczy, Laurent
    Kitamura, Daisuke
    Haynes, Barton F.
    Kelsoe, Garnett H.
    JOURNAL OF IMMUNOLOGY, 2016, 196
  • [7] Mode of interaction between the HIV-1-neutralizing monoclonal antibody 2F5 and its epitope
    Fiebig, Uwe
    Schmolke, Mirco
    Eschricht, Magdalena
    Kurth, Reinhard
    Denner, Joachim
    AIDS, 2009, 23 (08) : 887 - 895
  • [8] Interaction of Anti-HIV Type 1 Antibody 2F5 with Phospholipid Bilayers and Its Relevance for the Mechanism of Virus Neutralization
    Maeso, Ruben
    Huarte, Nerea
    Julien, Jean-Philippe
    Kunert, Renate
    Pai, Emil F.
    Nieva, Jose L.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2011, 27 (08) : 863 - 876
  • [9] Structural analysis of the epitope of the Anti-HIV antibody 2F5 sheds light into its mechanism of neutralization and HIV fusion
    Barbato, G
    Bianchi, E
    Ingallinella, P
    Hurni, WH
    Miller, MD
    Cilibertol, G
    Cortese, R
    Bazzo, R
    Shiver, JW
    Pessi, A
    JOURNAL OF MOLECULAR BIOLOGY, 2003, 330 (05) : 1101 - 1115
  • [10] A point mutation in the heavy chain complementarity-determining region 3 (HCDR3) significantly enhances the specificity of an anti-ROS1 antibody
    Lee, Hwa Kyoung
    Jin, Junyeong
    Kim, Sang Ii
    Kang, Min Jueng
    Yi, Eugene C.
    Kim, Ji Eun
    Park, Jong Bae
    Kim, Hyori
    Chung, Junho
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 493 (01) : 325 - 331